Byung Lee

Company: NeoImmuneTech Inc.

Job title: Senior Vice President & Chief Scientific Officer

Seminars:

IL-7 therapy: Oncology and beyond 11:30 am

NT-I7 (efineptakin alfa, a long-acting human IL-7) clinical development NT-I7 in combination with checkpoint inhibitors Potential clinical biomarkers in IL-7 treatmentRead more

day: Day One